FDA called to account over hacking

Share this article:

The FDA's biologics submission system was hacked during the October government shutdown, and the House Energy and Commerce Committee wants answers. Pharmalot provides a rundown of the breakdown, which includes the following:

  • The system was hacked in October, 5,000 users were notified, but drugmakers were not told until Nov. 8.
  • The committee's letter to FDA Commissioner Margaret Hamburg notes that the regulator did not give the industry a heads-up until the late afternoon/early evening of the Veteran's Day three-day weekend and notes that it has concerns the regulator may not have encrypted user passwords, since they asked 5,000 account holders to change them.

The committee's letter requests 11 points of information, including all breach-related documentation and how the agency finally concluded that only 14,000 accounts were touched.

The lawmakers note that the hacked files could include confidential business and medical information, among other items.

MM&M's sister publication SC Magazine has more on the hacking, which it says hasn't drawn much media attention.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.